Finnish Genome Editing Center, a new LSRI led by Dr. Juha Klefström. FinGEEC has been endorsed new emerging technology platform status by the BF’s SAB in 2016. New services under this core are being developed, and they will include gene editing validation with SURVEYOR assays and Sanger sequencing,  stem cell editing and in vivo editing to generate gene engineered mice. For inquiries of the present status of LSRI development, please contact the LSRI director.